Publications by authors named "Naimish Patel"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

269

Total Likes

375

Extended Reach

2,161,420

Social Features

166
D
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Jeremy Cole, Mona Bafadhel, Stephanie A Christenson, Alberto Papi, Dave Singh, Elizabeth Laws

July 2023

Videos about Article: user user

2 2 164 5 176

View All Article and Social Media Activity
P
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.
Luke J Laffin, Stephen J Nicholls, Russell S Scott, Peter M Clifton, John Baker, Naimish Patel

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule.
Annemie Deiteren, Emmanuel Krupka, Lieselot Bontinck, Karine Imberdis, Griet Conickx, Naimish Patel

Eur Respir J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.
Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, Jeffrey G Leflein, Philippe Bégin, Naimish Patel, Kiran Patel

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
Marcus Maurer, Thomas B Casale, Sarbjit S Saini, Moshe Ben-Shoshan, Ana M Giménez-Arnau, Naimish Patel, Kiran Patel

J Allergy Clin Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
Eric L Simpson, Jonathan I Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Naimish Patel

J Am Acad Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel, Naimish Patel

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
Mirna Chehade, Evan S Dellon, Jonathan M Spergel, Margaret H Collins, Marc E Rothenberg, Naimish Patel

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study.
Pierre-Francois Clot, Christine Farenc, Benjamin T Suratt, Tillmann Krahnke, Agnes Tardat, Naimish Patel

Respir Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Robert F Spiera, Sebastian Unizony, Kenneth J Warrington, Jennifer Sloane, Angeliki Giannelou, Naimish Patel

N Engl J Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials.
Gil Yosipovitch, Nicholas Mollanazar, Sonja Ständer, Shawn G Kwatra, Brian S Kim, Naimish Patel

Nat Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies.
Jorge F Maspero, Claus Bachert, Fernando J Martinez, Nicola A Hanania, Benjamin Ortiz, Naimish Patel

J Asthma Allergy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
Evan S Dellon, Marc E Rothenberg, Margaret H Collins, Ikuo Hirano, Mirna Chehade, Kiran Patel, Naimish Patel

N Engl J Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Naimish Patel

Lancet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis.
Cecilia Kristensson, Annika Åstrand, Scott Donaldson, Ron Goldwater, Raolat Abdulai, Naimish Patel

J Cyst Fibros· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
Joaquim Mullol, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W Hellings, Naimish Patel

J Allergy Clin Immunol Pract· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Omar S Usmani, MeiLan K Han, David A Kaminsky, James Hogg, Josephine Hjoberg, Naimish Patel

Chest· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, Naimish Patel

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
William W Busse, Sally E Wenzel, Thomas B Casale, J Mark FitzGerald, Megan S Rice, Naimish Patel

Lancet Respir Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven Pillars of Small Airways Disease in Asthma and COPD: Supporting Opportunities for Novel Therapies.
Omar S Usmani, MeiLan K Han, David A Kaminsky, James Hogg, Josephine Hjoberg, Naimish Patel

Chest· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Jennifer D Hamilton, Sivan Harel, Brian N Swanson, William Brian, Zhen Chen, Naimish Patel

Clin Exp Allergy· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
Tanya M Laidlaw, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W Hellings, Naimish Patel

Ann Allergy Asthma Immunol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
François-Xavier Lescure, Hitoshi Honda, Robert A Fowler, Jennifer Sloane Lazar, Genming Shi, Naimish Patel

Lancet Respir Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Ashish Bansal, Eric L Simpson, Amy S Paller, Elaine C Siegfried, Andrew Blauvelt, Naimish Patel

Am J Clin Dermatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function.
Ian D Pavord, Salman Siddiqui, Alberto Papi, Jonathan Corren, Lawrence D Sher, Naimish Patel

J Asthma Allergy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis